Breast cancer in African-American women

Oncologist

Volumn 10, Issue 1, 2005, Pages 1-14

  Newman, Lisa A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

African American women; Breast cancer; Outcome disparities

Indexed keywords

AROMATASE INHIBITOR; CYCLIN D1; CYCLIN D2; CYCLIN E; CYTOCHROME P450; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; PROTEIN P21; PROTEIN P27; PROTEIN P53; TAMOXIFEN;

AFRICAN AMERICAN; BONE DENSITY; BREAST CANCER; CANCER GENETICS; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; ENVIRONMENTAL FACTOR; EUROPEAN AMERICAN; FAT INTAKE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMOBILIZATION; INCIDENCE; LIFESTYLE; MASTECTOMY; MORTALITY; OBESITY; ONSET AGE; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIOECONOMICS; THROMBOEMBOLISM;

AFRICAN AMERICANS; BREAST NEOPLASMS; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; QUALITY OF HEALTH CARE; SOCIAL CLASS;

EID: 12844270607     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.10-1-1     Document Type: Review

References (117)

1. Ries L, Eisner M, Kosary M. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002.
2. Ries L, Eisner M, Kosary M. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute, 2003.
3. Mayberry RM, Stoddard-Wright C. Breast cancer risk factors among black women and white women: similarities and differences. Am J Epidemiol 1992;136:1445-1456.
4. Mayberry RM. Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54. Ann Epidemiol 1994;4:205-213.
5. Bernstein L, Teal CR, Joslyn S et al. Ethnicity-related variation in breast cancer risk factors. Cancer 2003;97:222-229.
6. National Cancer Data Base. Patterns of diagnosis and treatment, 1995-2000. National Cancer Database. http://web.facs.org/ncdbbmr/ncdbbenchmarks. cfm. Accessed August, 2004.
7. Krieger N. Social class and the black/white crossover in the age-specific incidence of breast cancer: a study linking census-derived data to population-based registry records. Am J Epidemiol 1990;131:804-814.
8. Pathak DR, Osuch JR, He J. Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer 2000;88(suppl):1230-1238.
9. Palmer JR, Wise LA, Horton NJ et al. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst 2003;95:478-483.
10. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. Am J Epidemiol 2000;152:950-964.
11. Flegal KM, Carroll MD, Ogden CL et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1728-1732.
12. Forshee RA, Storey ML, Ritenbaugh C. Breast cancer risk and lifestyle differences among premenopausal and postmenopausal African-American women and white women. Cancer 2003;97(suppl):280-288.
13. Ijaduola TG, Smith EB. Pattern of breast cancer among white-American, African-American, and nonimmigrant west-African women. J Natl Med Assoc 1998;90:547-551.
14. Ihekwaba FN. Breast cancer in Nigerian women. Br J Surg 1992;79:771-775.
15. Ikpatt OF, Kuopio T, Collan Y. Proliferation in African breast cancer: biology and prognostication in Nigerian breast cancer material. Mod Pathol 2002;15:783-789.
16. Ikpatt OF, Kuopio T, Ndoma-Egba R et al. Breast cancer in Nigeria and Finland: epidemiological, clinical and histological comparison. Anticancer Res 2002;22:3005-3012.
17. Newman B, Mu H, Butler LM et al. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 1998;279:915-921.
18. Gao Q, Neuhausen S, Cummings S et al. Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet 1997;60:1233-1236.
19. Gao Q, Tomlinson G, Das S et al. Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 2000;107:186-191.
20. Dangel J, Wagner-Costalas J, Bove B et al. Novel germline BRCA1 mutation (155del4) in an African American with early-onset breast cancer. Hum Mutat 1999;14:545.
21. Mefford HC, Baumbach L, Panguluri RC et al. Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet 1999;65:575-578.
22. Arena J, Smith S, Plewinska M. BRCA1 mutations in African American women. Am J Hum Genet 1996;9:34.
23. Olopade OI, Fackenthal JD, Dunston G et al. Breast cancer genetics in African Americans. Cancer 2002;97:236-245.
24. Matthews A, Cummings S, Thompson S et al. Genetic testing of African Americans for susceptibility to inherited cancers: use of focus groups to determine factors contributing to participation. J Psychosoc Oncol 2000;18:1-19.
25. Lerman C, Hughes C, Benkendorf J et al. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol Biomarkers Prev 1999;8:361-367.
26. Hughes C, Gomez-Caminero A, Benkendorf J et al. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 1997;32:51-62.
27. Cummings SR, Duong T, Kenyon E et al. Serum estradiol level and risk of breast cancer during treatment with raloxifene. JAMA 2002;287:216-220.
28. Hankinson SE, Willett WC, Manson JE et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-1299.
29. Key TJ, Appleby PN, Reeves GK et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-1226.
30. Zeleniuch-Jacquotte A, Shore RE, Koenig KL et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 2004;90:153-159.
31. Sturgeon SR, Potischman N, Malone KE et al. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Cancer Causes Control 2004;15:45-53.
32. Randolph JF Jr, Sowers M, Bondarenko IV et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555-1561.
33. Lasley BL, Santoro N, Randolf JF et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002;87:3760-3767.
34. Nelson DA, Darga LL, Simon MS et al. Radial bone density and breast cancer risk in white and African-American women. Osteoporos Int 2004;15:535-540.
35. Poola I, Clarke R, DeWitty R et al. Functionally active estrogen receptor isoform profiles in the breast tumors of African American women are different from the profiles in breast tumors of Caucasian women. Cancer 2002;94:615-623.
36. Newman LA, Bunner S, Carolin K et al. Ethnicity related differences in the survival of young breast carcinoma patients. Cancer 2002;95:21-27.
37. Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 2003;97:134-147.
38. Fisher B, Costantino JP, Wickerham DL et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-1388.
39. Hartmann LC, Schaid DJ, Woods JE et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84.
40. Rebbeck TR, Levin AM, Eisen A et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999;91:1475-1479.
41. Freedman A, Graubard B, Rao S et al. Estimates of the number of U.S. women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 2003;95:526-532.
42. Gail M, Costantino J, Bryant J et al. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 1999;91:1829-1846.
43. Gail MH, Brinton LA, Byar DP et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-1886.
44. Bondy ML, Lustbader ED, Halabi S et al. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994;86:620-625.
45. Rockhill B, Spiegelman D, Byrne C et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-366.
46. Spiegelman D, Colditz GA, Hunter D et al. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86:600-607.
47. Costantino JP, Gail M, Pee D et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91:1541-1548.
48. Newman LA, Rockhill B, Bondy ML et al. Validation of the Gail Breast Cancer risk assessment model in African American women based on a multi-center case-control study of 3,283 African American and 5,974 White American women. Proc Am Soc Clin Oncol 2002;21:976.
49. Newman LA, Gail MH, Selvan M et al. Proposed revision of the Gail breast cancer risk assessment model for African American women. Proc Am Soc Clin Oncol 2003;22:52.
50. Feig SA. Effect of service screening mammography on population mortality from breast carcinoma. Cancer 2002;95:451-457.
51. Ward E, Jemal A, Cokkinides V et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004;54:78-93.
52. Clegg LX, Li FP, Hankey BF et al. Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study. Arch Intern Med 2002;162:1985-1993.
53. National Health Interview Survey. Mammography utilization, NHIS Website. http://www.cdc.gov/nchs/nhis.htm. Accessed August 2004.
54. Humphrey L, Helfand M, Chan B et al. Breast cancer screening: a summary of the evidence. Ann Intern Med 2004;137:344-346.
55. Royak-Schaler R, Rose DP. Mammography screening and breast cancer biology in African American women - a review. Cancer Detect Prev 2002;26:180-191.
56. Jones BA, Kasl SV, Curnen MG et al. Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer 1995;75:2103-2113.
57. McCarthy EP, Burns RB, Coughlin SS et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med 1998;128:729-736.
58. Patterson SK, Helvie MA, Joynt LK et al. Mammographic appearance of breast cancer in African-American women: report of 100 consecutive cases. Acad Radiol 1998;5:2-8.
59. Freeman HP, Wasfie TJ. Cancer of the breast in poor black women. Cancer 1989;63:2562-2569.
60. Liberman L, Freeman H, Chandra S et al. Carcinoma detection at the Breast Examination Center of Harlem. Cancer 2002;95:8-14.
61. Bassett MT, Krieger N. Social class and black-white differences in breast cancer survival. Am J Public Health 1986;76:1400-1403.
62. Coates RJ, Clark WS, Eley JW et al. Race, nutritional status, and survival from breast cancer. J Natl Cancer Inst 1990;82:1684-1692.
63. Gordon NH, Crowe JP, Brumberg DJ et al. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 1992;135:609-618.
64. Ansell D, Whitman S, Lipton R et al. Race, income, and survival from breast cancer at two public hospitals. Cancer 1993;72:2974-2978.
65. Neale AV. Racial and marital status influences on 10 year survival from breast cancer. J Clin Epidemiol 1994;47:475-483.
66. Eley JW, Hill HA, Chen VW et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994;272:947-954.
67. Perkins P, Cooksley CD, Cox JD. Breast cancer. Is ethnicity an independent prognostic factor for survival? Cancer 1996;78:1241-1247.
68. Simon MS, Severson RK. Racial differences in survival of female breast cancer in the Detroit metropolitan area. Cancer 1996;77:308-314.
69. Franzini L, Williams AF, Franklin J et al. Effects of race and socioeconomic status on survival of 1,332 black, Hispanic, and white women with breast cancer. Ann Surg Oncol 1997;4:111-118.
70. Howard DL, Penchansky R, Brown MB. Disaggregating the effects of race on breast cancer survival. Fam Med 1998;30:228-235.
71. Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 1998;82:1310-1318.
72. Yood MU, Johnson CC, Blount A et al. Race and differences in breast cancer survival in a managed care population. J Natl Cancer Inst 1999;91:1487-1491.
73. El-Tamer MB, Homel P, Wait RB. Is race a poor prognostic factor in breast cancer? J Am Coll Surg 1999;189:41-45.
74. Roetzheim RG, Gonzalez EC, Ferrante JM et al. Effects of health insurance and race on breast carcinoma treatments and outcomes. Cancer 2000;89:2202-2213.
75. Newman LA, Mason J, Cote D et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer 2002;94:2844-2854.
76. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 2002;94:490-496.
77. Newman LA, Theriault R, Clendinnin N et al. Treatment choices and response rates in African-American women with breast carcinoma. Cancer 2003;97:246-252.
78. Newman LA, Kuerer HM, Hunt KK et al. Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol 1999;6:241-248.
79. Pierce L, Fowble B, Solin LJ et al. Conservative surgery and radiation therapy in black women with early stage breast cancer. Patterns of failure and analysis of outcome. Cancer 1992;69:2831-2841.
80. Elledge RM, Clark GM, Chamness GC et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 1994;86:705-712.
81. Li CI, Malone KE, Daling JR. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prev 2002;11:601-607.
82. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 2003;163:49-56.
83. McCaskill-Stevens W, Bryant J, Costantino J et al. Incidence of contralateral breast cancer (CBC), endometrial cancer (EC), and thromboembolic events (TE) in African American women receiving tamoxifen for treatment of primary breast cancer. Am Soc Clin Oncol 2000:269a.
84. Baum M, Budzar AU, Cuzick J et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet 2002;359:2131-2139.
85. Xie HG, Prasad HC, Kim RB et al. CYP2C9 allelic variants: ethnic distribution and functional significance. Adv Drug Deliv Rev 2002;54:1257-1270.
86. Stearns V, Davidson NE, Flockhart DA. Pharmacogenetics in the treatment of breast cancer. Pharmacogenomics J 2004;4:143-153.
87. Newman LA, Kuerer HM, Hunt KK et al. Response to induction chemotherapy in black and white patients with locally advanced breast cancer. Breast J 2000;6:242-246.
88. Hershman D, Weinberg M, Rosner Z et al. Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst 2003;95:1545-1548.
89. Breen N, Wesley MN, Merrill RM et al. The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study. Ethn Dis 1999;9:111-125.
90. Chu K, Lamar C, Freeman H. Racial disparities in breast cancer survival rates: separating factors that affect diagnosis from factors that affect treatment. Cancer 2003;97:2853-2860.
91. Roach M 3rd, Cirrincione C, Budman D et al. Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. Cancer J Sci Am 1997;3:107-112.
92. Fisher ER, Redmond C, Fisher B et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Prognostic discriminants for 8-year survival for node-negative invasive breast cancer patients. Cancer 1990;65:2121-2128.
93. Dignam JJ. Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin 2000;50:50-64.
94. Dignam JJ. Efficacy of systemic adjuvant therapy for breast cancer in African-American and Caucasian women. J Natl Cancer Inst Monogr 2001:36-43.
95. Albain KS, Unger JM, Hutchins LF et al. Outcome of African Americans on Southwest Oncology Group (SWOG) breast cancer adjuvant therapy trials. San Antonio Breast Cancer Symposium, San Antonio, TX, 2003;21.
96. Van Ness PH, Kasl SV, Jones BA. Religion, race, and breast cancer survival. Int J Psychiatry Med 2003;33:357-375.
97. Henderson PD, Fogel J. Support networks used by African American breast cancer support group participants. ABNF J 2003;14:95-98.
98. Henderson PD, Gore SV, Davis BL et al. African American women coping with breast cancer: a qualitative analysis. Oncol Nurs Forum 2003;30:641-647.
99. Michalec B, Van Willigen M, Wilson K et al. The race gap in support group participation by breast cancer survivors: real or artifact? Eval Rev 2004;28:123-143.
100. Farmer BJ, Smith ED. Breast cancer survivorship: are African American women considered? A concept analysis. Oncol Nurs Forum 2002;29:779-787.
101. Newman L, Jackson K. Breast cancer in African American women: the evolution of the Sisters Network, Inc., A National African American Breast Cancer Survivor Advocate Organization. Breast Diseases: A Yearbook Quarterly 2002;14:122-124.
102. Health Insurance Coverage: 2001, Volume 2003. U.S. Census Bureau, 2001.
103. Boyer-Chammard A, Taylor TH, Anton-Culver H. Survival differences in breast cancer among racial/ethnic groups: a population-based study. Cancer Detect Prev 1999;23:463-473.
104. Burri SH, Landry JC, Davis LW. Breast conservation is an effective option in Black, medically indigent patients. J Natl Med Assoc 2002;94:453-458.
105. Connor CS, Touijer AK, Krishnan L et al. Local recurrence following breast conservation therapy in African-American women with invasive breast cancer. Am J Surg 2000;179:22-26.
106. Nicolaou N, Fowble B, Hanlon A. The impact of regional lymphatic irradiation and of the extent of axillary lymph node dissection on regional control in patients with early-stage, node-positive breast cancer, treated with breast-conserving therapy. Proc Am Soc Clin Oncol 1999;18:266.
107. Velanovich V, Yood MU, Bawle U et al. Racial differences in the presentation and surgical management of breast cancer. Surgery 1999;125:375-379.
108. Arnold RE, Frykberg ER, Kilkenny JW et al. Trends in surgical treatment of breast cancer at an urban teaching hospital: a six-year review. Am Surg 1998;64:107-111.
109. Muss HB, Hunter CP, Wesley M et al. Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience. Cancer 1992;70:2460-2467.
110. Shiao Y, Chen V, Scheer W et al. Racial disparity in the association of p53 gene alterations with breast cancer survival. Cancer Res 1995;55:1485-1490.
111. Guillemette C, Millikan R, Newman B et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 2000;60:950-956.
112. Mehrotra J, Ganpat M, Kanaan Y et al. Estrogen receptor/progesterone receptor-negative breast cancers of young African American women have a higher frequency of methylation of multiple genes than those of Caucasian women. Clin Cancer Res 2004;10:2052-2057.
113. Chen Z, Wu AH, Gauderman W et al. Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol 2004;159:140-147.
114. Porter PL, Lund MJ, Lin MG et al. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma. Cancer 2004;100:2533-2542.
115. Millikan RC, Player J, De Cotret AR et al. Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Res 2004;6:R264-R274.
116. Li Y, Millikan RC, Bell DA et al. Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res 2004;6:R460-R473.
117. Jones BA, Kasl SV, Howe CL et al. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics. Cancer 2004;101:1293-1301.